JP6488236B2 - 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ - Google Patents

可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ Download PDF

Info

Publication number
JP6488236B2
JP6488236B2 JP2015549567A JP2015549567A JP6488236B2 JP 6488236 B2 JP6488236 B2 JP 6488236B2 JP 2015549567 A JP2015549567 A JP 2015549567A JP 2015549567 A JP2015549567 A JP 2015549567A JP 6488236 B2 JP6488236 B2 JP 6488236B2
Authority
JP
Japan
Prior art keywords
antibody
fgfr4
sfgfr2
mouse anti
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015549567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016504590A5 (enExample
JP2016504590A (ja
Inventor
チャターベディ，シャリニ
プラテロ，スソ
シーゲル，デリック
Original Assignee
ヤンセン バイオテツク，インコーポレーテツド
ヤンセン バイオテツク，インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヤンセン バイオテツク，インコーポレーテツド, ヤンセン バイオテツク，インコーポレーテツド filed Critical ヤンセン バイオテツク，インコーポレーテツド
Publication of JP2016504590A publication Critical patent/JP2016504590A/ja
Publication of JP2016504590A5 publication Critical patent/JP2016504590A5/ja
Application granted granted Critical
Publication of JP6488236B2 publication Critical patent/JP6488236B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2015549567A 2012-12-21 2013-12-17 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ Expired - Fee Related JP6488236B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261740466P 2012-12-21 2012-12-21
US61/740,466 2012-12-21
PCT/US2013/075699 WO2014099933A1 (en) 2012-12-21 2013-12-17 Sensitive multiplex immunoassay for soluble fibroblast growth factor receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018190141A Division JP2019053068A (ja) 2012-12-21 2018-10-05 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ

Publications (3)

Publication Number Publication Date
JP2016504590A JP2016504590A (ja) 2016-02-12
JP2016504590A5 JP2016504590A5 (enExample) 2018-11-29
JP6488236B2 true JP6488236B2 (ja) 2019-03-20

Family

ID=50979111

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015549567A Expired - Fee Related JP6488236B2 (ja) 2012-12-21 2013-12-17 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ
JP2018190141A Pending JP2019053068A (ja) 2012-12-21 2018-10-05 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018190141A Pending JP2019053068A (ja) 2012-12-21 2018-10-05 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ

Country Status (17)

Country Link
EP (1) EP2936153B1 (enExample)
JP (2) JP6488236B2 (enExample)
CN (2) CN114062680A (enExample)
AU (1) AU2013362937A1 (enExample)
CY (1) CY1121482T1 (enExample)
DK (1) DK2936153T3 (enExample)
ES (1) ES2705328T3 (enExample)
HR (1) HRP20190157T1 (enExample)
HU (1) HUE042184T2 (enExample)
LT (1) LT2936153T (enExample)
PL (1) PL2936153T3 (enExample)
PT (1) PT2936153T (enExample)
RS (1) RS58147B1 (enExample)
SI (1) SI2936153T1 (enExample)
SM (1) SMT201900068T1 (enExample)
TR (1) TR201820490T4 (enExample)
WO (1) WO2014099933A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108551763B (zh) * 2015-12-18 2021-11-09 瓦里泰细胞有限公司 一种确定样品中靶分子丰度的方法
CN110488014A (zh) * 2019-08-27 2019-11-22 成都和同易创生物科技有限公司 一种检测结直肠癌转移潜能的试剂盒及其使用方法
CN116165180A (zh) * 2022-11-16 2023-05-26 安徽恩禾生物技术有限公司 一种vegf荧光免疫层析测定试剂盒及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008410A1 (en) * 1995-03-13 2003-01-09 Hechinger Mark K. Immunoassay apparatus, kit and methods
US6632526B1 (en) * 1997-10-14 2003-10-14 Luminex Corporation Precision fluorescently dyed particles and methods of making and using same
EP1697420A2 (en) * 2003-12-19 2006-09-06 Five Prime Therapeutics, Inc. Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
WO2005086647A2 (en) * 2004-02-23 2005-09-22 University Of Maryland, Baltimore Immuno-pcr method for the detection of a biomolecule in a test sample
EP1904846A4 (en) * 2005-06-29 2009-03-18 Rules Based Medicine Inc METHOD AND KITS FOR THE DIAGNOSIS OF ACUTE CORONARY SYNDROME
CN101201357B (zh) * 2007-11-05 2012-06-06 广州益善生物技术有限公司 一种用于乳腺癌早期诊断的液相芯片试剂盒及其制备方法
US8216783B2 (en) * 2008-04-14 2012-07-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Over-expression and mutation of a tyrosine kinase receptor FGFR4 in tumors
CN101392172B (zh) * 2008-11-01 2012-04-18 厦门大学 羧基化荧光编码微球及其合成方法
CN102131524B (zh) * 2008-11-07 2014-05-14 星系生物科技责任有限公司 成纤维细胞生长因子受体2的单克隆抗体
EP3702371B1 (en) * 2009-03-25 2022-11-02 Genentech, Inc. Anti-fgfr3 antibodies and methods using same
CN101526535B (zh) * 2009-04-14 2011-04-20 河南省豫康生物工程技术有限公司 多种肿瘤标志物联合检测液相芯片及其制备方法
CN101592655A (zh) * 2009-06-23 2009-12-02 毅新兴业（北京）科技有限公司 液体生物芯片系统
CN101881772A (zh) * 2010-07-01 2010-11-10 南京工业大学 梅毒螺旋体(tp)抗体检验试剂盒及其制备和检测方法
WO2012088337A1 (en) * 2010-12-23 2012-06-28 Prometheus Laboratories Inc. Drug selection for malignant cancer therapy using antibody-based arrays

Also Published As

Publication number Publication date
HRP20190157T1 (hr) 2019-03-22
PT2936153T (pt) 2019-02-18
WO2014099933A1 (en) 2014-06-26
TR201820490T4 (tr) 2019-01-21
CN104995512A (zh) 2015-10-21
AU2013362937A1 (en) 2015-07-02
EP2936153A1 (en) 2015-10-28
RS58147B1 (sr) 2019-02-28
LT2936153T (lt) 2019-01-25
EP2936153A4 (en) 2016-05-25
DK2936153T3 (en) 2019-02-25
JP2016504590A (ja) 2016-02-12
EP2936153B1 (en) 2018-11-28
JP2019053068A (ja) 2019-04-04
SMT201900068T1 (it) 2019-02-28
SI2936153T1 (sl) 2019-02-28
PL2936153T3 (pl) 2019-05-31
HK1215070A1 (en) 2016-08-12
ES2705328T3 (es) 2019-03-22
HUE042184T2 (hu) 2019-06-28
CN114062680A (zh) 2022-02-18
CY1121482T1 (el) 2020-05-29

Similar Documents

Publication Publication Date Title
Grainger et al. TGF-β in blood: a complex problem
CN106461670B (zh) 糖化蛋白质试验
CN105765386B (zh) 用于检测中和抗体的竞争性配体结合测定法
KR102549704B1 (ko) Pivka-ii의 측정 방법, 및 pivka-ii 면역측정 시약 또는 키트의 제조 방법
US20120295814A1 (en) CA-125 Immune Complexes as Biomarkers of Ovarian Cancer
CN106546744A (zh) 通过粪便血红蛋白、转铁蛋白和pkm2联合检测评定结肠直肠癌的方法及相应试剂盒
Thorpe et al. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures
JP2019053068A (ja) 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ
EP3132268B1 (en) Immunoassay for the detection of chromogranin a
KR20170118858A (ko) L-fabp의 면역학적 측정 방법 및 해당 방법에 사용되는 측정 시약
US20020004212A1 (en) Detection of surface-associated human leukocyte elastase
WO2022221877A2 (en) Lateral flow analysis and breast cancer
CN107505459B (zh) 定量检测人h-fabp的时间分辨荧光免疫层析试纸条、试剂盒及其制备方法
US20190011451A1 (en) Methods and compositions for assaying blood levels of legumain
Ma et al. Bead-based spontaneous Raman codes for multiplex immunoassay
WO2023154780A1 (en) Anti-her2/neu antibodies and methods of use
US20100047830A1 (en) Compositions and methods for detecting cancers in a subject
HK40069150A (en) Sensitive multiplex immunoassay for soluble fibroblast growth factor receptors
US8697368B2 (en) Diagnostic marker for lung cancer comprising HPαR as active ingredient
CN112639475A (zh) Dlbcl的预后指数中的胸苷激酶(tk-1)
KR101187674B1 (ko) 이단 면역 크로마토그래피를 이용한 효소 활성 측정법
US20240210402A1 (en) Method for detecting oral neoplastic lesion, test reagent, test kit and therapeutic composition
HK1215070B (en) Sensitive multiplex immunoassay for soluble fibroblast growth factor receptors
CN108267595A (zh) 一种基于双分子荧光互补技术的Myo检测试剂盒、制备及使用方法
KR20180099722A (ko) 예측 방법 및 상기 방법에 유용한 키트

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151102

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161208

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170926

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180223

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180605

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20181005

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20181127

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190225

R150 Certificate of patent or registration of utility model

Ref document number: 6488236

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees